Contact Information
Company Information
Company
Janux Therapeutics
Annual Revenue
10588000.0
Technologies
Outlook
WP Engine
WordPress.org
Mobile Friendly
reCAPTCHA
Google Font API
Google Tag Manager
Google Analytics
Lever
Gravity Forms
Typekit
Micro
Remote
AI
Keywords
biotechnology
biotechnology: pharmaceutical preparations
health care
biotechnology research
tumor-activated
t cell immunotherapy
tractr
egfr-tractr
psma-tractr
immuno-oncology
cancer treatment
clinical trials
antigen-targeting
bispecific molecules
precision oncology
t cell engager
immunomodulators
tumor microenvironment
drug candidates
selective modulation
immune response
metastatic castration-resistant prostate cancer
mcrpc
drug development
therapeutic index
safety profile
efficacy studies
protein engineering
cytokine release syndrome
crs
monoclonal antibodies
cancer immunotherapy
safety concerns
drug targeting
pharmacokinetics
dose escalation
biologics development
tumor antigens
antibody-linked drugs
immune system stimulation
tumor-specific activation
protease-cleavable linkers
pharmaceutical collaborations
partnering opportunities
fda approval
advanced therapies
research collaboration
prostate cancer
investor relations
scientific publications
clinical pipelines
novel therapeutics
immune checkpoint blockade
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans